OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An in vitro-transcribed circular RNA targets the mitochondrial inner membrane cardiolipin to ablate EIF4G2+/PTBP1+ pan-adenocarcinoma
Zunyong Feng, Xuanbo Zhang, Jing Zhou, et al.
Nature Cancer (2023) Vol. 5, Iss. 1, pp. 30-46
Closed Access | Times Cited: 23

Showing 23 citing articles:

The therapeutic potential of circular RNAs
Eoghan Thomas O’Leary, Yanyi Jiang, Lasse S. Kristensen, et al.
Nature Reviews Genetics (2025)
Closed Access | Times Cited: 6

Recent advances and perspectives on the development of circular RNA cancer vaccines
Zhaohui Gong, Wentao Hu, Chengwei Zhou, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2

In vivo vectorization and delivery systems for gene therapies and RNA-based therapeutics in oncology
Julie Schock Vaiani, Mans Broekgaarden, Jean‐Luc Coll, et al.
Nanoscale (2025)
Closed Access | Times Cited: 1

Efficient circularization of protein-encoding RNAs via a novel cis-splicing system
Shao-Jun Qi, Huiming Wang, Guopeng Liu, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 17, pp. 10400-10415
Open Access | Times Cited: 6

New strategies for lung cancer diagnosis and treatment: applications and advances in nanotechnology
Jiaqi Feng, Pengpeng Zhang, Dingli Wang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 6

Engineering circular RNA medicines
Xiaofei Cao, Zhengyi Cai, Jinyang Zhang, et al.
Nature Reviews Bioengineering (2024)
Closed Access | Times Cited: 6

Spatiotemporal multi-omics: exploring molecular landscapes in aging and regenerative medicine
Liuxi Chu, Wenjia Wang, Xin-Pei Gu, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 5

A New Mechanism in Steroid-Induced Osteonecrosis of the Femoral Head and the Protective Role of Simvastatin
X. Li, Shi-da Qian, Dan Chen, et al.
Experimental Cell Research (2025), pp. 114471-114471
Open Access

Unlocking the potential of circular RNA vaccines: a bioinformatics and computational biology perspective
Xuyuan Liu, S H Wang, Yunan Sun, et al.
EBioMedicine (2025) Vol. 114, pp. 105638-105638
Closed Access

Circular RNA circDCUN1D4 suppresses hepatocellular carcinoma development via targeting the miR-590-5p/ TIMP3 axis
Hongyu Li, Bing‐Jian Su, Yan Jiang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access

Circular RNAs modulate cancer drug resistance: advances and challenges
Jinghan Hua, Zhe Wang, Xiangfei Cheng, et al.
Cancer Drug Resistance (2025)
Open Access

Role of noncoding RNA and protein interaction in pancreatic cancer
Zhang Li, Tingting Zhang, Yang Xiao-juan, et al.
Chinese Medical Journal (2025)
Open Access

Emergence of Small Nucleic Acids as Drugs in Precision Medicine
Xing Cheng, Yan Wang, Tingting Zhang, et al.
Clinical Pharmacology & Therapeutics (2025)
Closed Access

Circular RNA discovery with emerging sequencing and deep learning technologies
Jinyang Zhang, Fangqing Zhao
Nature Genetics (2025)
Closed Access

Sirt6 deficiency exacerbates angiotensin II-induced lipid nephrotoxicity by affecting PLD6-derived cardiolipin metabolism in podocytes
Yiqun Hao, Jijia Hu, Zongwei Zhang, et al.
Cellular Signalling (2025), pp. 111858-111858
Closed Access

Unlock the sustained therapeutic efficacy of mRNA
Dinglingge Cao, Meng Tian, Zhengwei Liu, et al.
Journal of Controlled Release (2025), pp. 113837-113837
Closed Access

An oncolytic circular RNA therapy
Alex G. Hamilton, Michael J. Mitchell
Nature Cancer (2024) Vol. 5, Iss. 1, pp. 5-7
Closed Access | Times Cited: 3

Pyroptosis: Induction and inhibition strategies for immunotherapy of diseases
Junjun Wu, Hong Wang, Pu Gao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4195-4227
Open Access | Times Cited: 3

mRNA vaccines as cancer therapies
Shaoxiong Huang, Haiying Que, Manni Wang, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 1

RNA modification‐related EIF4G2 is an immunotherapy determinant in osteosarcoma: A single‐cell sequencing analysis
Haocheng Qin, Shu Yang, Zhennan Feng, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 10, pp. 4547-4561
Closed Access

Regulating Immune Responses Induced by PEGylated Messenger RNA–Lipid Nanoparticle Vaccine
Hyein Jo, Jaewhoon Jeoung, Won‐Ho Kim, et al.
Vaccines (2024) Vol. 13, Iss. 1, pp. 14-14
Open Access

Page 1

Scroll to top